IDEAS home Printed from https://ideas.repec.org/h/pal/palchp/978-0-230-21105-6_9.html
   My bibliography  Save this book chapter

GlaxoSmithKline and its Corporate Citizenship Programme

In: Multinationals in their Communities

Author

Listed:
  • Ian W. Jones

    (University of Oxford)

  • Michael G. Pollitt

    (University of Cambridge)

  • David Bek

    (University of Cambridge)

Abstract

GSK’s history is based around a series of mergers and acquisitions, dating back to the opening of John K. Smith’s drug store in Philadelphia in 1830. Key dates in the firm’s history include: the building of the world’s first medicine factory by Thomas Beecham in 1859, the opening of the Wellcome Tropical Research Laboratories in 1902 and the registration of Glaxo as a trademark for dried baby milk in 1906 (GSK, 2005i). In 2000 Smithkline Beecham (which had formed in 1989) and Glaxo Wellcome (who had merged in 1995) joined forces to create GSK — one of the world’s leading research-based pharmaceutical companies (GSK, 2005k). The firm is headquartered in the UK with operational headquarters based in the US and operations in 118 countries. The firm has two main divisions — pharmaceutical and consumer healthcare. The pharmaceutical division (which generates about 85% of GSK’s sales) deals predominantly with vaccines and prescriptions drugs, whilst the consumer healthcare side produces over-the-counter medicines, healthcare products and nutritional drinks. Well-known products include, Zantac and Paxil/Seroxat (pharmaceuticals) and Macleans toothpaste and Lucozade (consumer healthcare).

Suggested Citation

  • Ian W. Jones & Michael G. Pollitt & David Bek, 2007. "GlaxoSmithKline and its Corporate Citizenship Programme," Palgrave Macmillan Books, in: Multinationals in their Communities, chapter 9, pages 260-281, Palgrave Macmillan.
  • Handle: RePEc:pal:palchp:978-0-230-21105-6_9
    DOI: 10.1057/9780230211056_9
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:palchp:978-0-230-21105-6_9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.